☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
GSK
GSK Reports the Results for Blenrep (belantamab mafodotin) in P-III Clinical Trial for the Treatment of Multiple Myeloma
November 27, 2023
GSK Reports Results of Jemperli in Combination with Chemotherapy in P-III Trial for the Treatment of Endometrial Cancer
October 30, 2023
GSK and Hansoh Signed a License Agreement for HS-20089 to Treat Gynaecologic Cancer
October 23, 2023
GSK Receives the EMA’s CHMP Positive Opinion of Jemperli (dostarlimab) for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Ca...
October 17, 2023
Top 20 Monoclonal Antibodies Based on 2022 Total Revenue
September 26, 2023
GSK Receives the US FDA’s Approval of Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
September 18, 2023
Load more...
Back to Home